Clinical Trial

Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Alcohol activates reward systems in different brain areas, i.e., the nucleus accumbens, dorsal striatum, extended amygdala, and prefrontal cortex. These areas are all part of the reward neurocircuitry, which plays an important role in the development of addiction. A former study performed on rodents has shown that a specific area of the forebrain, the septal nuclei, is associated with the feeling of reward and, hence, addiction when stimulated. However, whether the septal area is involved in reward and addiction in humans is sparsely investigated. The purpose of this brain-imaging study is to assess how the septal nuclei react to alcohol-related pictures shown to participants diagnosed with alcohol use disorder while lying in an MRI scanner, compared to people without a diagnosis of alcohol use disorder. This might give us a better understanding of how the septal nuclei is involved in reward and addiction.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-04; most recent amendment 2025-06-10.
Status change: Not Yet Recruiting → Recruiting 2025-04-22
Trial Details
NCT Number NCT06866379
Lead Sponsor Anders Fink-Jensen, MD, DMSci
Collaborators: Neurobiology Research Unit, Rigshospitalet, The foundation of Mr. Ivan Nielsen, King Christian X foundation
Conditions Alcohol Use Disorder
Enrollment 25 participants
Start Date 2025-05-07
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-11